{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:18Z","timestamp":1761058158445},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1007\/bf00635708","type":"journal-article","created":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T13:12:39Z","timestamp":1101474759000},"page":"53-59","source":"Crossref","is-referenced-by-count":7,"title":["Bioavailability and diuretic effect of furosemide during long-term treatment of chronic respiratory failure"],"prefix":"10.1007","volume":"28","author":[{"given":"H.","family":"Ogata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kawatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Haga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00635708_CR1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/BF00607089","volume":"24","author":"H Ogata","year":"1983","unstructured":"Ogata H, Zugarni S, Ejima A, Kawatsu Y (1983) Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers. Eur J Clin Pharmacol 24: 791\u2013796","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00613429","volume":"9","author":"B Beermann","year":"1975","unstructured":"Beermann B, Dalen E, Lindstrom B, Rosen A (1975) On the fate of furosemide in man. Eur J Clin Pharmacol 9: 57\u201361","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/clpt.1981.189","volume":"30","author":"R Fuller","year":"1981","unstructured":"Fuller R, Hoppel C, Ingalls ST (1981) Furosemide kinetics in patients with hepatic cirrhosis with ascites. Clin Pharmacol Ther 30: 461\u2013467","journal-title":"Clin Pharmacol Ther"},{"key":"BF00635708_CR4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cpt1974164659","volume":"16","author":"CM Huang","year":"1974","unstructured":"Huang CM, Atkinson AJ, Levin M, Levin NW, Quintanilla A (1974) Pharmacokinetics of furosemide in advanced renal failure. Clin Pharmacol Ther 16: 659\u2013666","journal-title":"Clin Pharmacol Ther"},{"key":"BF00635708_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cpt1977212141","volume":"21","author":"HJ Rose","year":"1976","unstructured":"Rose HJ, O'Malley K, Pruitt AW (1976) Depression of renal clearance of furosemide in man by azotemia. Clin Pharmacol Ther 21: 141\u2013146","journal-title":"Clin Pharmacol Ther"},{"key":"BF00635708_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cpt197722170","volume":"22","author":"B Beermann","year":"1977","unstructured":"Beermann B, Dalen E, Lindstrom B (1977) Elimination of furosemide in healthy subjects and in those with renal failure. Clin Pharmacol Ther 22: 70\u201378","journal-title":"Clin Pharmacol Ther"},{"key":"BF00635708_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00606681","volume":"13","author":"F Andreasen","year":"1978","unstructured":"Andreasen F, Hansen HE, Mikkelsen E (1978) Pharmacokinetics of furosemide in anephric patients and in normal subjects. Eur J Clin Pharmacol 13: 41\u201348","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00637617","volume":"21","author":"E Riva","year":"1982","unstructured":"Riva E, Fossali E, Bettinelli A (1982) Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis. Eur J Clin Pharmacol 21: 303\u2013306","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR9","first-page":"570","volume":"5","author":"C Allgulander","year":"1980","unstructured":"Allgulander C, Beermann B, Sjogren A (1980) Frusemide pharmacokinetics in patients with liver disease. Clin Pharmacol Ther 5: 570\u2013575","journal-title":"Clin Pharmacol Ther"},{"key":"BF00635708_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00554663","volume":"20","author":"E Keller","year":"1981","unstructured":"Keller E, Hoppe-Seyler G, Mumm R, Schollmeyer P (1981) Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide. Eur J Clin Pharmacol 20: 27\u201333","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/clpt.1982.101","volume":"31","author":"RK Verbeeck","year":"1982","unstructured":"Verbeeck RK, Patwardhan RV, Villeneuve JP, Wilkinson GR, Branch RA (1982) Furosemide disposition in cirrhosis. Clin Pharmacol Ther 31: 719\u2013725","journal-title":"Clin Pharmacol Ther"},{"key":"BF00635708_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00548399","volume":"22","author":"G Gonzalez","year":"1982","unstructured":"Gonzalez G, Arancibia A, Rivas MI, Caro P, Antezana C (1982) Pharmacokinetics of furosemide in patients with hepatic cirrhosis. Eur J Clin Pharmacol 22: 315\u2013320","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2125.1977.tb00682.x","volume":"4","author":"RA Branch","year":"1977","unstructured":"Branch RA, Roberts CJC, Homeida M, Levine D (1977) Determinations of response to frusemide in normal subjects. Br J Clin Pharmacol 4: 121\u2013127","journal-title":"Br J Clin Pharmacol"},{"key":"BF00635708_CR14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/jps.2600711006","volume":"71","author":"ES Waller","year":"1982","unstructured":"Waller ES, Hamilton SF, Massarella JW, Sharanevych MA, Smith RV, Yakatan GJ, Doluisio JT (1982) Disposition and absolute bioavailability of furosemide in healthy males. J Pharm Sci 71: 1105\u20131108","journal-title":"J Pharm Sci"},{"key":"BF00635708_CR15","first-page":"178","volume":"15","author":"MR Kelly","year":"1973","unstructured":"Kelly MR, Cutler RE, Forrey AW, Kimpel BM (1973) Pharmacokinetics of orally administered furosemide. Clin Pharmacol Ther 15: 178\u2013186","journal-title":"Clin Pharmacol Ther"},{"key":"BF00635708_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01059438","volume":"7","author":"LZ Benet","year":"1979","unstructured":"Benet LZ (1979) Pharmacokinetics\/pharmacodynamics of furosemide in man: a review. J Pharmacokinet Biopharm 7: 1\u201327","journal-title":"J Pharmacokinet Biopharm"},{"key":"BF00635708_CR17","doi-asserted-by":"crossref","unstructured":"Fine A, Henderson IS, Morgan DR, Tilstone WJ (1977) Malabsorption of furosemide caused by phenytoin. Brit Med J: 1061\u20131062","DOI":"10.1136\/bmj.2.6094.1061"},{"key":"BF00635708_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00611907","volume":"14","author":"E Riva","year":"1978","unstructured":"Riva E, Farina P, Tognoni G, Bottino S, Orrico C, Pardi G (1978) Pharmacokinetics of furosemide in gestosis of pregnancy. Eur J Clin Pharmacol 14: 361\u2013366","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJM197611042951902","volume":"295","author":"DD Brown","year":"1976","unstructured":"Brown DD, Juhl RP (1976) Decreased bioavailability of digoxin due to antacids and kaolin-pectin. N Engl J Med 295: 1034\u20131037","journal-title":"N Engl J Med"},{"key":"BF00635708_CR20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0016-5085(81)90122-0","volume":"80","author":"M Uribe","year":"1981","unstructured":"Uribe M, Casian C, Rojas S, Sierra JG, Go VLM (1981) Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers. Gastroenterology 80: 661\u2013665","journal-title":"Gastroenterology"},{"key":"BF00635708_CR21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2125.1979.tb00997.x","volume":"7","author":"R Verbeeck","year":"1979","unstructured":"Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, De Schepper PJ (1979) Effect of aluminum hydroxide on diflunisal absorption. Br J Clin Pharmacol 7: 519\u2013522","journal-title":"Br J Clin Pharmacol"},{"key":"BF00635708_CR22","first-page":"337","volume":"8","author":"DE Smith","year":"1980","unstructured":"Smith DE, Lin ET, Benet LZ (1980) Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metab Dispos 8: 337\u2013342","journal-title":"Drug Metab Dispos"},{"key":"BF00635708_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00561400","volume":"12","author":"F Andreasen","year":"1977","unstructured":"Andreasen F, Mikkelsen E (1977) Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol 12: 15\u201322","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00560456","volume":"14","author":"F Andreasen","year":"1978","unstructured":"Andreasen F, Pedersen OL, Mikkelsen E (1978) Distribution, elimination and natriuretic effect of furosemide in patients with severe arterial hypertension. Eur J Clin Pharmacol 14: 237\u2013244","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00635708_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2125.1983.tb02183.x","volume":"16","author":"F Andreasen","year":"1983","unstructured":"Andreasen F, Hausen U, Husted SE, Jansen JA (1983) The pharmacokinetics of frusemide are influenced by age. Br J Clin Pharmacol 16: 391\u2013397","journal-title":"Br J Clin Pharmacol"},{"key":"BF00635708_CR26","first-page":"1","volume":"21","author":"MR Kelly","year":"1977","unstructured":"Kelly MR, Blair AD, Forrey AW, Smidt NA, Cutler RE (1977) A comparison of the diuretic response to oral and intravenous furosemide in \u201cdiuretic-resistant\u201d patients. Curr Ther Res 21: 1\u20139","journal-title":"Curr Ther Res"},{"key":"BF00635708_CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ki.1982.134","volume":"22","author":"S Kaojarern","year":"1982","unstructured":"Kaojarern S, Day B, Brater DC (1982) The time course of delivery of furosemide into urine: An independent determinant of overall response. Kidney Int 22: 69\u201374","journal-title":"Kidney Int"},{"key":"BF00635708_CR28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1248\/bpb1978.6.684","volume":"6","author":"K Uchino","year":"1983","unstructured":"Uchino K, Isozaki S, Amano J, Tanaka N, Saitoh Y, Nakagawa F, Tamura Z, Oka H (1983) Clinical pharmacokinetics and diuretic effect of furosemide on plain tablet and retard capsule with normal subjects and cirrhotic patients. J Pharm Dyn 6: 684\u2013691","journal-title":"J Pharm Dyn"},{"key":"BF00635708_CR29","first-page":"163","volume":"33","author":"A Ebihara","year":"1983","unstructured":"Ebihara A, Oka T (1983) Pharmacodynamic and pharmacokinetic study of a slow-release formulation of furosemide in man. Arzneimittelforsch\/Drug Res 33: 163\u2013166","journal-title":"Arzneimittelforsch\/Drug Res"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00635708.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00635708\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00635708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T09:28:25Z","timestamp":1585992505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00635708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["BF00635708"],"URL":"https:\/\/doi.org\/10.1007\/bf00635708","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}